Get the Stockscreener App
6.40
4.75%
0.29
After Hours:
6.40
Generation Bio Co stock is traded at $6.40, with a volume of 24,688.
It is up +4.75% in the last 24 hours and up +7.93% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$6.11
Open:
$6.14
24h Volume:
24,688
Relative Volume:
0.08
Market Cap:
$43.11M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.945
EPS:
-6.7728
Net Cash Flow:
$-81.69M
1W Performance:
+2.07%
1M Performance:
+7.93%
6M Performance:
+65.25%
1Y Performance:
-73.22%
1-Day Range:
$6.14
$6.40
1-Week Range:
$5.96
$6.48
52-Week Range:
$3.004
$25.70
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
6.40 | 41.15M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Why analysts upgrade Generation Bio Co. stockTake Profit & Weekly Breakout Watchlists - newser.com
Is it time to cut losses on Generation Bio Co.2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Tools to monitor Generation Bio Co. recovery probabilityPortfolio Return Report & AI Powered Market Entry Ideas - newser.com
Is Generation Bio Co. stock a safe investment in uncertain marketsJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Analyzing net buyer seller activity in Generation Bio Co.Quarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Will Generation Bio Co. stock recover after recent dropDividend Hike & Weekly Breakout Watchlists - newser.com
Will Generation Bio Co. outperform the marketPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Will Generation Bio Co. stock see insider buyingJuly 2025 Retail & Verified Momentum Watchlists - newser.com
AI-based system offers insights on how polymers can be engineered for use in next-generation bioelectronics - Phys.org
What analysts say about Generation Bio Co stockGrowth vs. Value Investing & High Yield Trading Alerts - earlytimes.in
What technical models suggest about Generation Bio Co.’s comebackGap Down & Daily Profit Maximizing Tips - newser.com
Using economic indicators to assess Generation Bio Co. potentialWeekly Volume Report & Daily Profit Focused Screening - newser.com
Is Generation Bio Co. stock entering bullish territoryJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
How to track smart money flows in Generation Bio Co.July 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
IFFCO launches ‘DharAmrut’ – a next-generation bio stimulant to boost crop yield - The News Mill
IFFCO launches 'DharAmrut'a next-generation bio stimulant to boost crop yield - ANI News
Sanghani, Patel launch IFFCO’s Next-Gen Bio Stimulant ‘DharAmrut’ - Indian Cooperative
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Generation Bio Co Stock (GBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
| Howze Yalonda | CHIEF LEGAL OFFICER |
Oct 15 '24 |
Option Exercise |
2.42 |
3,347 |
8,100 |
15,169 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):